187 results
8-K
EX-99.1
EXEL
Exelixis Inc
6 Feb 24
Exelixis Announces Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Corporate Update
4:28pm
candidates in 2024. We believe the associated restructuring of our business, announced in January, will enable us to rapidly execute on our goals … biotech leader in oncology, as well as Exelixis’ belief that its associated restructuring will enable the company to rapidly execute on its goals
DEFA14A
i3n4rmb6hdzvpbl02
15 May 23
Additional proxy soliciting materials
8:05am
DFAN14A
l7xbxzc1yfylqljgagd8
11 May 23
Additional proxy materials by non-management
12:27pm
DEFC14A
bbx 22yezd89tjj
1 May 23
Proxy in contested solicitation
4:58pm
PREC14A
i56f373geef0vbzw
17 Apr 23
Preliminary proxy with contested solicitation
4:57pm